Dr Talbots Cooling Perineal Pad Liquid
NDC Package 70797-104-01
Package Information
Dr Talbots Cooling Perineal Pad (water, aloe barbadensis leaf juice, bioflavonoids, calendula officinalis flower extract, chamomilla recutita flower extract, citric acid, decyl glucoside, glycerin, lactic acid, levulinic acid, mentha piperita (peppermint) oil, sodium cocoamphoacetate, potassium sorbate) liquids is helps relieve pain and swelling from hemmorrhoids and children.Temperoray relief from irritation.BurningDiscomfort. This formulation utilizes a liquid delivery system. Marketed by Talbot's Pharmaceuticals Family Products, Llc., this product is identified by NDC 70797-104 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 844379 - witch hazel 50 % Medicated Pad
- RxCUI: 844379 - witch hazel 500 MG/ML Medicated Pad
- RxCUI: 844379 - witch hazel 50 % Medicated Wipes
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70797 - Talbot's Pharmaceuticals Family Products, Llc.
- 70797-104 - Dr Talbots Cooling Perineal Pad
- 70797-104-01 - 120 g in 1 PACKAGE
- 70797-104 - Dr Talbots Cooling Perineal Pad
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70797-104-01 identifies a specific commercial package of 120 g in 1 package of Dr Talbots Cooling Perineal Pad, a human over the counter drug labeled by Talbot's Pharmaceuticals Family Products, Llc.. This liquid is formulated for topical use and contains witch hazel as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Talbot's Pharmaceuticals Family Products, Llc. on August 08, 2024. The current certification is valid through December 31, 2026.
How is this Talbot's Pharmaceuticals Family Products, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70797010401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.